VEXOL Side Effects

6592731-2 | Growth Retardation
on Jan 27, 2010 Male patient from GERMANY , child 8 years of age, was diagnosed with conjunctival disorder and was treated with Vexol (View Usage). Patient experienced the following unwanted or unexpected effects: growth retardation. Vexol dosage: Ophthalmic. During the same period patient was treated with TRIAMCINOLON (TRIAMCINOLONE) (View Triamcinolon (triamcinolone) Review and Triamcinolon (triamcinolone) Label ).

6551142-6 | Growth Retardation
Patient was taking Vexol (View Usage). Patient had the following side effects: growth retardation on Jan 08, 2010 from GERMANY Additional patient health information: Male patient , child 8 years of age, was diagnosed with conjunctival disorder and. Vexol dosage: Ophthalmic.

6234695-7 | Cough, Dyspnoea, Eye Disorder, Eyelid Margin Crusting, Fatigue, Gait Disturbance, Muscle Fatigue, Nervous System Disorder, Night Sweats
Adverse event was reported on Jun 16, 2009 by a Female patient taking Vexol (View Usage) (Dosage: 1 Drop Every 12 Hours Ophthalmic) was diagnosed with corneal infection and. Location: UNITED STATES , 23 years of age, weighting 105.0 lb, After Vexol was administered, patient had the following side effects: cough, dyspnoea, eye disorder, eyelid margin crusting, fatigue, gait disturbance, muscle fatigue, nervous system disorder, night sweats.

5362799-X | Astigmatism, Graft Complication, Ocular Hypertension, Suture Rupture
on May 31, 2007 Male patient from FRANCE , 24 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Vexol (View Usage). Patient experienced the following unwanted or unexpected effects: astigmatism, graft complication, ocular hypertension, suture rupture. Vexol dosage: Eye Drops, Suspension; 1 Gtt Qd Os.


5337144-6 | Corneal Thinning, Refraction Disorder
on May 11, 2007 Male patient from FINLAND , 38 years of age, was diagnosed with prophylaxis, analgesic effect and was treated with Vexol (View Usage). Patient had the following side effects: corneal thinning, refraction disorder. Vexol dosage: See Image. During the same period patient was treated with VOLTAREN OPHTHALMIC (DICLOFENAC SODIUM) 0.1% SOLUTION (See Image) (View Voltaren Ophthalmic (diclofenac Sodium) 0.1% Solution Review and Voltaren Ophthalmic (diclofenac Sodium) 0.1% Solution Label ), OFTAQUIX (LEVOFLOXACIN) (View Oftaquix (levofloxacin) Review and Oftaquix (levofloxacin) Label ), CHLOROMYCETIN (CHLORAMPHENICOL) (View Chloromycetin (chloramphenicol) Review and Chloromycetin (chloramphenicol) Label ), OCULAC (POLYVIDONE) (View Oculac (polyvidone) Review and Oculac (polyvidone) Label ).

5337143-4 | Corneal Thinning, Hypermetropia, Refraction Disorder
Patient was taking Vexol (View Usage). After Vexol was administered, patient had the following side effects: corneal thinning, hypermetropia, refraction disorder on May 11, 2007 from FINLAND Additional patient health information: Male patient , 28 years of age, was diagnosed with prophylaxis, analgesic effect and. Vexol dosage: Eye Drops, Suspension 1 Gtt Operated Eye Bid Month, Starting After The 4 Day Ophthalmic. During the same period patient was treated with VOLTAREN OPHTHALMIC (DICLOFENAC SODIUM) 0.1% (Eye Drops, Solution 1 Gtt Operated Eye Tid X 2 Days Ophthalmic) (View Voltaren Ophthalmic (diclofenac Sodium) 0.1% Review and Voltaren Ophthalmic (diclofenac Sodium) 0.1% Label ), OFTAQUIX (LEVOFLOXACIN) (View Oftaquix (levofloxacin) Review and Oftaquix (levofloxacin) Label ), CHLOROMYCETIN (CHLORAMPHENICOL) (View Chloromycetin (chloramphenicol) Review and Chloromycetin (chloramphenicol) Label ), OCULAC (POLYVIDONE) (View Oculac (polyvidone) Review and Oculac (polyvidone) Label ).

5337141-0 | Corneal Thinning, Refraction Disorder
Adverse event was reported on May 11, 2007 by a Female patient taking Vexol (View Usage) (Dosage: See Image) was diagnosed with prophylaxis, analgesic effect and. Location: FINLAND , 32 years of age, Patient experienced the following unwanted or unexpected effects: corneal thinning, refraction disorder. During the same period patient was treated with VOLTAREN OPHTHALMIC (DICLOFENAC SODIUM) 0.1%EYE DROPS (See Image) (View Voltaren Ophthalmic (diclofenac Sodium) 0.1%eye Drops Review and Voltaren Ophthalmic (diclofenac Sodium) 0.1%eye Drops Label ), OFTAQUIX (LEVOFLOXACIN) (View Oftaquix (levofloxacin) Review and Oftaquix (levofloxacin) Label ), CHLOROMYCETIN (CHLORAMPHENICOL) (View Chloromycetin (chloramphenicol) Review and Chloromycetin (chloramphenicol) Label ), OCULAC (POLYVIDONE) (View Oculac (polyvidone) Review and Oculac (polyvidone) Label ).

5325787-5 | Angiogram Retina Abnormal, Eye Pain, Intraocular Pressure Increased, Retinal Dystrophy, Scotoma
on Apr 24, 2007 Female patient from FRANCE , 47 years of age, was diagnosed with keratitis interstitial and was treated with Vexol (View Usage). Patient had the following side effects: angiogram retina abnormal, eye pain, intraocular pressure increased, retinal dystrophy, scotoma. Vexol dosage: Eye Drops, Suspension Ophthalmic. During the same period patient was treated with TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5266714-9 | Astigmatism, Graft Complication, Ocular Hypertension, Suture Rupture
on Feb 26, 2007 Male patient from FRANCE , 24 years of age, was treated with Vexol (View Usage). After Vexol was administered, patient had the following side effects: astigmatism, graft complication, ocular hypertension, suture rupture. Vexol dosage: Eye Drops, Suspension.

5109855-9 | Rash Macular
Patient was taking Vexol (View Usage). Patient experienced the following unwanted or unexpected effects: rash macular on Sep 18, 2006 from UNITED STATES Additional patient health information: Male patient , 87 years of age, weighting 190.0 lb, was diagnosed with cataract operation and. Vexol dosage: 1 Drop 4 Times Daily Left Eye. During the same period patient was treated with NEVANAC (View Nevanac Review and Nevanac Label ), ZYMAR (View Zymar Review and Zymar Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

4862686-7 | Angina Pectoris, Arrhythmia, Arthralgia, Atrial Fibrillation, Blood Cholesterol Increased, Cardiac Disorder, Gastrooesophageal Reflux Disease, Gout, Heart Rate Irregular
Adverse event was reported on Sep 30, 2005 by a Male patient taking Vexol (View Usage) (Dosage: ) was diagnosed with eye inflammation, hypokalaemia, hypertension, cardiac failure, nausea (What is nausea?) and. Location: UNITED STATES , 66 years of age, weighting 251.3 lb, Patient had the following side effects: angina pectoris, arrhythmia (What is arrhythmia?), arthralgia, atrial fibrillation (What is atrial fibrillation?), blood cholesterol increased, cardiac disorder, gastrooesophageal reflux disease, gout (What is gout?), heart rate irregular. During the same period patient was treated with KLOR CON (View Klor-con Review and Klor-con Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), PERIOGARD (View Periogard Review and Periogard Label ), DOXYCLIN (View Doxyclin Review and Doxyclin Label ). Patient was hospitalized and became disabled.

4590111-2 | Anorexia, Asthenia, Blood Iron Decreased, Coma, Disseminated Intravascular Coagulation, Haemodialysis, Hypocalcaemia, Hypotension, Hypoxia
on Feb 04, 2005 Female patient from , 79 years of age, was treated with Vexol (View Usage). After Vexol was administered, patient had the following side effects: anorexia, asthenia, blood iron decreased, coma, disseminated intravascular coagulation, haemodialysis, hypocalcaemia, hypotension, hypoxia. Vexol dosage: Opht. During the same period patient was treated with SPIRAMYCINE/METRONIDAZOLE (View Spiramycine/metronidazole Review and Spiramycine/metronidazole Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), NIMESULIDE (View Nimesulide Review and Nimesulide Label ), FORMALDEHIDE/TYROTHRICIN (View Formaldehide/tyrothricin Review and Formaldehide/tyrothricin Label ).